The North American Fetal Therapy Network consensus statement: prenatal surveillance of uncomplicated monochorionic

Mert Ozan Bahtiyar1, Stephen P Emery, Jodi S Dashe

  • 1Departments of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, and University of Texas Health Science Center at Houston, Houston, Texas; the Departments of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas, and Columbia University Medical Center, New York, New York; the Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts; Evergreen Hospital, Kirkland, Washington; the Department of Pediatrics, Division of Cardiology, and the Fetal Treatment Center, University of California, San Francisco, San Francisco, California; the Divisions of Maternal Fetal Medicine, Departments of Obstetrics and Gynecology, Weill Cornell Medical College and New York Hospital Queens, New York, New York, and Warren Alpert Medical School of Brown University, Providence, Rhode Island; and the Division of Maternal and Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland.